Aims: To investigate the ocular surface temperature gradient in eyes with bacterial corneal ulcers. Methods: Prospective examination of 12 eyes with bacterial corneal ulcers (group 1) and 12 control eyes (group 2). Infrared thermal imaging (Tomey TG 1000) was used to study the temperature of the ocular surface. The mean, minimum and maximum temperature of the ocular surface and temperature course over a time period of 10 s of sustained eye opening were evaluated. Furthermore, a correlation between the overall corneal temperature and the temperature at the base of the corneal ulcers was determined. Results: A significant difference between both groups was present. Mean corneal temperature was 35.6°C ± 0.9 in group 1 and 34.8°C ± 0.8 in group 2 (p = 0.033). The temperature course over 10 s of sustained eye opening was –0.6°C ± 0.4 in group 1 and –0.3°C ± 0.2 in group 2 (p = 0.045). There was a close correlation between the mean temperature at the base of the corneal ulcer and the overall corneal temperature (r = 0.92, p < 0.001). Conclusion: Infrared thermal imaging can be used to objectively determine the increased ocular surface temperature in patients with bacterial corneal ulcers. The use of dynamic thermography may offer new options to monitor ocular surface alterations.

Keywords:
Corneal ulcer, Ocular surface temperature, Thermography, Infrared thermal imaging
1.
McLeod SD, LaBree LD, Tayyanipour R, et al: The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 1995;102:1943–1948.
2.
Bourcier T, Thomas F, Borderie V, et al: Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 2003;87:834–838.
3.
Erie J, Nevitt M, Hodge D, et al: Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol 1993;111:1665–1671.
4.
Saini JS, Jain AK, Kumar S, et al: Neural network approach to classify infective keratitis. Curr Eye Res 2003;27:111–116.
5.
Rietveld RP, ter Riet G, Bindels PJ, et al: Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. BMJ 2004;329:206–210.
6.
Ficker L, Kirkness CM, McCartney AC, et al: Microbial keratitis – the false negative. Eye 1991;5:549–559.
7.
Jones DB: Decision-making in the management of microbial keratitis. Ophthalmology 1981;88:814–820.
8.
Pepose JS, Wilhelmus KR: Divergent approaches to the management of corneal ulcers. Am J Ophthalmol 1992;114:630–632.
9.
McDonnell PJ: Empirical or culture-guided therapy for microbial keratitis? A plea for data. Arch Ophthalmol 1996;114:84–87.
10.
Seal DV, Barrett SP, McGill JI: Aetiology and treatment of acute bacterial infection of the external eye. Br J Ophthalmol 1982;66:357–360.
11.
Barone S, Paoli A, Razionale AV: Assessment of chronic wounds by three-dimensional optical imaging based on integrating geometrical, chromatic, and thermal data. Proc Inst Mech Eng H 2011;225:181–193.
12.
Purslow C, Wolffsohn JS, Santodomingao-Rubido J: The effects of contact lens wear on dynamic ocular surface temperature. Cont Lens Anterior Eye 2005;28:29–36.
13.
de Ortueta D, Magnago T, Triefenbach N, et al: In vivo measurements of thermal load during ablation in high-speed laser corneal refractive surgery. J Refract Surg 2012;28:53–58.
14.
Kamao T, Yamaguchi M, Kawasaki S, et al: Screening for dry eye with newly developed ocular surface thermographer. Am J Ophthalmol 2011;151:782–791.
15.
Klamann MK, Maier AK, Gonnermann J, et al: Measurement of dynamic ocular surface temperature in healthy subjects using a new ocular thermography device. Curr Eye Res 2012;37:678–683.
16.
Mori A, Oguchi Y, Okusawa Y, et al: Use of high-speed, high-resolution thermography to evaluate the tear film layer. Am J Ophthalmol 1997;124:729–735.
17.
Jones BF: A reappraisal of the use of infrared thermal image analysis in medicine. IEEE Trans Med Imaging 1998;17:1019–1027.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.